Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1987 1
1994 1
1995 1
1996 1
1998 1
2000 1
2001 1
2003 1
2004 6
2005 1
2006 3
2007 5
2008 6
2009 4
2010 3
2011 2
2012 4
2013 7
2014 7
2015 6
2016 6
2017 2
2018 4
2019 1
2020 1
2021 2
2022 0
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 24324104

73 results
Results by year
Filters applied: . Clear all
Page 1
Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with a combination of cisplatin/docetaxel and concurrent thoracic irradiation.
Azuma K, Sasada T, Kawahara A, Hattori S, Kinoshita T, Takamori S, Ichiki M, Imamura Y, Ikeda J, Kage M, Kuwano M, Aizawa H. Azuma K, et al. Cancer Chemother Pharmacol. 2009 Aug;64(3):565-73. doi: 10.1007/s00280-008-0907-3. Epub 2009 Jan 3. Cancer Chemother Pharmacol. 2009. PMID: 19123003
Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.
Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T. Friedel G, et al. J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100967 Clinical Trial.
73 results